[ORGANIZATION]
Elevidys
Featured in 2 tracked stories · first seen
Situations
Duchenne muscular dystrophy drug regulation in Brazil
2 clusters · 27 sources · last updated
Latest: Anvisa and Roche cancel Elevidys registration in Brazil
In August 2026, Brazil’s National Health Surveillance Agency (Anvisa) issued two significant regulatory decisions regarding treatments for Duchenne muscular dystrophy (DMD). First, Anvisa approved the registration of Du
Also covered in
-
Slovenian Health Insurance Institute denies funding for boy's Duchenne therapy in US
[HEALTH] · 3 sources ·